Career Opportunities at MRC-Holland
MRC-Holland is a fast-growing biotechnology company based in the Amsterdam Baarsjes. MRC-Holland consists of a multinational team of more than 80 employees. MRC-Holland is the inventor of the Multiplex Ligation-dependent Probe Amplification (MLPA) technique, a sensitive method to detect copy number changes in genes. MLPA is used in hundreds of labs and hospitals worldwide for many different applications, including mutation detection in hereditary diseases and subtyping of tumours. Because of continuous growth, we are looking for:



Which personal data do we collect of our applicants? Please see our privacy policy.
Improved Products
P090-BRCA2
Breast and ovarian cancer, hereditary (HBOC)
P239-BRCA1 region
Breast cancer
P188-22q13
Phelan-Mcdermid syndrome
P045-BRCA2/CHEK2
Breast and ovarian cancer, hereditary (HBOC); Susceptibility to breast cancer; Susceptibility to other cancer types
P315-EGFR
Tumours, solid
Newsletter  |  Home  |  Privacy Policy  |  Terms and Conditions  |  Search  |  Sitemap  |  Copyright © 2019 MRC-Holland